Entresto and Invokana drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Entresto (sacubitril; valsartan) and Invokana (canagliflozin). Common drug interactions include diarrhoea among females and dizziness among males.

The phase IV clinical study analyzes what interactions people have when they take Entresto and Invokana. It is created by eHealthMe based on reports of 55 people who take the same drugs from the FDA, and is updated regularly.

What is Entresto?

Entresto has active ingredients of sacubitril; valsartan. eHealthMe is studying from 126,628 Entresto users. Check the latest studies of Entresto.

What is Invokana?

Invokana has active ingredients of canagliflozin. It is often used in diabetes. eHealthMe is studying from 29,937 Invokana users. Check the latest studies of Invokana.



On Jul, 04, 2026

55 people who take Entresto and Invokana together, and have interactions are studied.

Entresto and Invokana drug interactions.

What are the common drug interactions of Entresto and Invokana, by gender? *:

female:

  1. Diarrhoea
  2. Dizziness postural
  3. Drug ineffective
  4. Dyspepsia (indigestion)
  5. Fluid retention (an abnormal accumulation of fluid in the blood)
  6. Headache (pain in head)
  7. Hunger
  8. Hypotension (abnormally low blood pressure)
  9. Insomnia (sleeplessness)
  10. Lung neoplasm malignant (cancer tumour of lung)

male:

  1. Dizziness
  2. Dyspnoea (difficult or laboured respiration)
  3. Weight increased
  4. Back pain
  5. Ventricular arrhythmia (problem with the rate or rhythm of the heartbeat)
  6. Chest discomfort
  7. Hyperkalaemia (damage to or disease of the kidney)
  8. Metabolic acidosis (body produces too much acid, or when the kidneys are not removing enough acid from the body)
  9. Nausea (feeling of having an urge to vomit)
  10. Renal failure (kidney dysfunction)

What are the common drug interactions of Entresto and Invokana, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Genital abscess (build up of pus in genital)
  2. Groin abscess (pus in groin)
  3. Pelvic abscess
  4. Perineal abscess
  5. Scrotal abscess (pus in scrotum)
  6. Scrotal gangrene (death of scrotum cells)
  7. Sepsis (a severe blood infection that can lead to organ failure and death)
  8. Septic shock (shock due to blood infection)
  9. Subcutaneous abscess
  10. Urinary tract infection

40-49:

  1. Angioedema (rapid swelling of the dermis)
  2. Lip swelling
  3. Swelling face
  4. Swollen tongue (swelling of tongue)
  5. Toxic epidermal necrolysis (a rare, life-threatening skin condition that is usually caused by a reaction to drugs causes wide spread skin destruction)
  6. Urticaria (rash of round, red welts on the skin that itch intensely)

50-59:

  1. Aphasia (damage to the parts of the brain that control language)
  2. Back pain
  3. Depression
  4. Gait disturbance
  5. Hypoaesthesia (reduced sense of touch or sensation)
  6. Memory impairment
  7. Tremor (trembling or shaking movements in one or more parts of your body)
  8. Visual impairment
  9. Cardiovascular disorder (heart diseases)
  10. Death

60+:

  1. Dizziness
  2. Dyspnoea (difficult or laboured respiration)
  3. Weight increased
  4. Back pain
  5. Ventricular arrhythmia (problem with the rate or rhythm of the heartbeat)
  6. Hyperkalaemia (damage to or disease of the kidney)
  7. Metabolic acidosis (body produces too much acid, or when the kidneys are not removing enough acid from the body)
  8. Herpes zoster
  9. Pneumonia
  10. Renal failure (kidney dysfunction)

What are the existing conditions these people have? *

  1. Cardiac Failure: 22 people, 40.00%
  2. Hyperkalemia (damage to or disease of the kidney): 12 people, 21.82%
  3. Type 2 Diabetes: 6 people, 10.91%
  4. High Blood Pressure: 5 people, 9.09%
  5. Chest Pain: 5 people, 9.09%
  6. Arrhythmias (irregular heartbeat): 4 people, 7.27%
  7. Parkinson's Disease: 3 people, 5.45%
  8. High Blood Cholesterol: 3 people, 5.45%
  9. Depression: 3 people, 5.45%
  10. Cardiac Disorder: 3 people, 5.45%

* Approximation only. Some reports may have incomplete information.

Do you take Entresto and Invokana?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Entresto and Invokana:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Entresto:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Invokana:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Entresto and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Invokana and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on sacubitril; valsartan and canagliflozin (the active ingredients of Entresto and Invokana, respectively), and Entresto and Invokana (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: